D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
DAWN holding history
Day One Biopharmaceuticals, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −21,626−100.0% | Sold out | Holders |
| Q1 2026 | 21,626 | $463.7K | <0.1% | −293−1.3% | Reduced | Holders |
| Q4 2025 | 21,919 | $204.3K | <0.1% | −56,053−71.9% | Reduced | Holders |
| Q3 2025 | 77,972 | $549.7K | <0.1% | −3,331−4.1% | Reduced | Holders |
| Q2 2025 | 81,303 | $528.5K | <0.1% | −1,767−2.1% | Reduced | Holders |
| Q1 2025 | 83,070 | $658.7K | <0.1% | −63,315−43.3% | Reduced | Holders |
| Q4 2024 | 146,385 | $1.85M | <0.1% | +3,250+2.3% | Added | Holders |
| Q3 2024 | 143,135 | $1.99M | <0.1% | −81,205−36.2% | Reduced | Holders |
| Q2 2024 | 224,340 | $3.09M | <0.1% | +121+0.1% | Added | Holders |
| Q1 2024 | 224,219 | $3.70M | <0.1% | +28,730+14.7% | Added | Holders |
| Q4 2023 | 195,489 | $2.85M | <0.1% | −739−0.4% | Reduced | Holders |
| Q3 2023 | 196,228 | $2.41M | <0.1% | −17,188−8.1% | Reduced | Holders |
| Q2 2023 | 213,416 | $2.55M | <0.1% | −210,963−49.7% | Reduced | Holders |
| Q1 2023 | 424,379 | $5.67M | <0.1% | −176,943−29.4% | Reduced | Holders |
| Q4 2022 | 601,322 | $12.9M | <0.1% | +34,174+6.0% | Added | Holders |
| Q3 2022 | 567,148 | $11.4M | <0.1% | +428,830+310.0% | Added | Holders |
| Q2 2022 | 138,318 | $2.48M | <0.1% | +138,318 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −13,404−100.0% | Sold out | Holders |
| Q4 2021 | 13,404 | $226.0K | <0.1% | +13,404 | New | Holders |